Wire · opportunities
GCCL Strengthens Asia-Pacific Presence at Asia Bio Partnering Forum 2026
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 8 September 2026 · Fusion42 review
GCCL, a South Korean clinical trial sample analysis company, participated as a Platinum Sponsor at Asia Bio Partnering Forum 2026 in Singapore to expand its clinical sample analysis and assay development services throughout the Asia-Pacific region and build collaborations with pharmaceutical companies, CROs, and regional stakeholders.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
You have a window to enter or expand in Asia-Pacific clinical trial services as GCCL is increasing regional partnerships and operational presence. This shift opens direct access to evolving analytical needs in drug development for mRNA, radiopharmaceuticals, and antibody therapies.
◆ Coverage
1 source · 8 Sep 2026
◆ Related on Wire
◆ Topics